Cefpodoxime proxetil and Indomethacin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cefpodoxime proxetil and Indomethacin. Common interactions include drug hypersensitivity among females and asthma among males.

The phase IV clinical study analyzes what interactions people who take Cefpodoxime proxetil and Indomethacin have. It is created by eHealthMe based on reports of 12 people who take Cefpodoxime proxetil and Indomethacin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 26, 2022

12 people who take Cefpodoxime proxetil and Indomethacin together, and have interactions are studied.


What is Cefpodoxime proxetil?

Cefpodoxime proxetil has active ingredients of cefpodoxime proxetil. eHealthMe is studying from 1,212 Cefpodoxime proxetil users for its effectiveness, alternative drugs and more.

What is Indomethacin?

Indomethacin has active ingredients of indomethacin. It is often used in gout. eHealthMe is studying from 14,317 Indomethacin users for its effectiveness, alternative drugs and more.

Number of Cefpodoxime proxetil and Indomethacin reports submitted per year:

Cefpodoxime proxetil and Indomethacin drug interactions.

Common Cefpodoxime Proxetil and Indomethacin drug interactions by gender *:

female:

  1. Drug hypersensitivity

male:

  1. Asthma
  2. Drug administration error
  3. Pneumonia
  4. Chronic kidney disease
  5. Drug ineffective
  6. Gastrooesophageal reflux disease

Common Cefpodoxime Proxetil and Indomethacin drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Drug hypersensitivity
  2. Asthma
  3. Drug administration error
  4. Pneumonia
  5. Chronic kidney disease
  6. Drug ineffective
  7. Gastrooesophageal reflux disease

Common conditions people have *:

  1. Asthma: 2 people, 16.67%
  2. Rickets (softening of bones): 1 person, 8.33%
  3. Infection: 1 person, 8.33%
  4. High Blood Pressure: 1 person, 8.33%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 8.33%
  6. Cardiac Failure Congestive: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Cefpodoxime proxetil and Indomethacin?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Cefpodoxime proxetil and Indomethacin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Cefpodoxime proxetil side effects:

Browse all side effects of Cefpodoxime proxetil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Indomethacin side effects:

Browse all side effects of Indomethacin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Cefpodoxime proxetil interactions:

Browse all interactions between Cefpodoxime proxetil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Indomethacin interactions:

Browse all interactions between Indomethacin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cefpodoxime proxetil and indomethacin (the active ingredients of Cefpodoxime proxetil and Indomethacin, respectively), and Cefpodoxime proxetil and Indomethacin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Cefpodoxime proxetil and Indomethacin.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: